International stem cell tourism and the need for effective regulation: Part II: Developing sound oversight measures and effective patient support

Kennedy Institute of Ethics Journal 20 (3):207-230 (2010)
  Copy   BIBTEX


Clinics and hospitals around the globe are offering stem cell treatments to persons with serious conditions for whom no effective therapies are available in their home countries. Many of these treatments, which are touted as cures for such conditions as Parkinson's and Alzheimer's Diseases, multiple sclerosis, and spinal cord injuries, have not gone through clinical trials that establish their safety and efficacy. Indeed, it is unclear whether some of them even utilize stem cells. State regulation of these therapies tends to be weak or nonexistent in some of the countries in which they are offered. This puts those who believe they must travel abroad for stem cell treatments at risk of injury from procedures that ..



    Upload a copy of this work     Papers currently archived: 91,349

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Scientific self-regulation—so good, how can it fail?Patrick L. Taylor - 2009 - Science and Engineering Ethics 15 (3):395-406.
Stem cell research: An ethical evaluation of policy options.Nikolaus Knoepffler - 2004 - Kennedy Institute of Ethics Journal 14 (1):55-74.
The ethics and politics of small sacrifices in stem cell research.Glenn McGee & Arthur L. Caplan - 1999 - Kennedy Institute of Ethics Journal 9 (2):151-158.
Moral complicity in induced pluripotent stem cell research.Mark T. Brown - 2009 - Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.


Added to PP

172 (#109,443)

6 months
4 (#818,853)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references